CHRISTINE FERNANDEZ: Open Payments
NPI 1275104705 · RANCHO MIRAGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,906 in 72 payments from 17 companies in 2025. Trend: 2023 $1,744 · 2024 $1,896 · 2025 $1,906
Food & beverage: $1,812Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $289 |
| Galderma Laboratories, L.P. | 10 | $286 |
| LEO Pharma Inc. | 7 | $245 |
| GENZYME CORPORATION | 3 | $196 |
| UCB, Inc. | 6 | $194 |
| Arcutis Biotherapeutics, Inc. | 9 | $179 |
| Novartis Pharmaceuticals Corporation | 6 | $133 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $112 |
| Verrica Pharmaceuticals Inc. | 2 | $49 |
| PFIZER INC. | 2 | $45 |
Products named: NEMLUVIO, ADBRY, DUPIXENT, Zoryve, Bimzelx, SKYRIZI, RINVOQ, COSENTYX.
Industry payments across CA — which companies pay providers there.
